Skip to main content
. 2021 Aug 12;32(2):938–949. doi: 10.1007/s00330-021-08205-0

Table 5.

Final version of the items and results for the follow up section

Statement Information to be included in the report Agreement (median) Consensus (IQR) Stability (p)
Clinical referrals

- pTNM (or ypTNM);

- Surgery performed: total vs sub-total gastrectomy; type of reconstruction (Billroth II vs Roux), type of lymphadenectomy (D1, D2 or D2 plus, D3);

The radiologist should point out in the radiological report if clinical information provided is not adequate.

 9 1.5 /
Technique

- Specify if correct distension of the residual stomach or anastomosis has been performed, the modality of distension (air or water), and the reasons for any failure to distension;

- Specify if gastric hypotonization has been carried out;

- Report any adverse reaction to intravenous contrast media (in that case, report the contrast agent administered);

- Report the presence of any movement artifact or problem that occurred during the CT examination;

- Report if examination performed with dual-energy technique.

- Report if important changes in the protocol compared to the reference examination.

 9 0 0.272
Findings
Loco-regional relapse

- Site of the relapse (gastric bed, duodenal stump, anastomosis/perianastomotic area);

- Dimension;

- Contact with/infiltration of anatomical and vascular structures.

 9 0 0.655
Lymphatic relapse

- Site of the recurrence (according to the JGCA number stations or anatomical description according to AJCC);

- Number of LN involved (expressed in ≥ 3 or ≥ 7);

- Dimension (short diameter of the largest LN for each station).

 9 1 0.398
Distant relapse

- Site;

- Number for each anatomical site: indicate if unique, or number up to max 3, or if > 3 indicate “multiple”;

- Size: indicate the maximum diameter of the largest lesion for each involved organ;

- If there are skeletal lesions, specify lesions at risk of fracture/vertebral canal invasion;

- If liver involvement, specify segments and contact/infiltration of major vascular structures;

- Specify the presence of ascites;

- Specify the presence of peritoneal carcinomatosis;

 9 0 0.317
Conclusions/advice

- Report if disease recurrence is present;

- Indicate possible accessible anatomical sites for histological sample/confirmation.

 8 2 /